The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II clinical trial of toripalimab in advanced solid tumors with POLE/POLD1 mutation.
 
Ying Jin
No Relationships to Disclose
 
Run-jie Huang
No Relationships to Disclose
 
Zong-jiong Mai
No Relationships to Disclose
 
Zhi-qiang Wang
No Relationships to Disclose
 
Yan-xia Shi
No Relationships to Disclose
 
Yu-hong Li
No Relationships to Disclose
 
Jian Xiao
No Relationships to Disclose
 
Xing Zhang
No Relationships to Disclose
 
Qi Zhao
No Relationships to Disclose
 
Ming Liu
Employment - HaploX Biotechnology
Honoraria - HaploX Biotechnology
Consulting or Advisory Role - HaploX Biotechnology
Research Funding - HaploX Biotechnology
 
Rui-hua Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; HenRui; Junshi Biosciences; KYM Biosciences; Merck Serono; Roche
 
Feng Wang
No Relationships to Disclose